Photodynamic Therapy of Actinic Keratoses With Alacare®

photonamic GmbH & Co. KG388 enrolled

Overview

This study aims to collect data on the frequency of SCCs in the Alacare®-treated area during an interval of two years after Alacare®-PDT.

Study Type

OBSERVATIONAL

Enrollment

388

Conditions

Actinic Keratosis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Written informed consent * Patients with 3 to 6 mild AK lesions on the hairless areas of the head and face which were treated with Alacare®-PDT according to the SPC

Locations (8)

Medizinisches Zentrum Bonn Friedensplatz

Bonn, Germany

Hautarztpraxis Prof. Kurzen

Freising, Germany

Hautärztliche Gemeinschaftspraxis Dr. med. Peter Dworzak Dr. med. Peter Radny

Friedrichshafen, Germany

Gemeinschaftspraxis Dres.Ina Röhrig-Petering und Holger Petering

Outcomes

Primary Outcomes

Number of SCCs in areas treated with Alacare®-PDT

Time frame: Two years after Alacare®-PDT

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.